tiprankstipranks
Ikena Oncology (IKNA)
NASDAQ:IKNA
US Market
Holding IKNA?
Track your performance easily

Ikena Oncology (IKNA) Financial Statements

97 Followers

Ikena Oncology Financial Overview

Ikena Oncology's market cap is currently ―. The company's EPS TTM is $-1.238; its P/E ratio is -1.40; Ikena Oncology is scheduled to report earnings on March 18, 2025, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue---$ 658.00K$ 1.19M
Gross Profit---$ 658.00K$ 1.19M
EBIT$ -10.22M$ -13.67M$ -15.64M$ -21.91M$ -19.50M
EBITDA$ -10.13M$ -13.18M$ -15.43M$ -21.60M$ -19.26M
Net Income Common Stockholders$ -10.23M$ -13.73M$ -16.15M$ -19.49M$ -17.34M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 138.03M$ 145.42M$ 157.35M$ 175.47M$ 196.93M
Total Assets$ 148.99M$ 157.49M$ 172.78M$ 192.09M$ 215.34M
Total Debt$ 8.39M$ 9.09M$ 9.74M$ 11.69M$ 12.34M
Net Debt$ -129.64M$ -136.33M$ -147.60M$ -163.78M$ -184.59M
Total Liabilities$ 14.76M$ 14.63M$ 17.43M$ 22.34M$ 28.15M
Stockholders Equity$ 134.23M$ 142.86M$ 155.35M$ 169.76M$ 155.34M
Cash Flow-
Free Cash Flow$ -8.75M$ -12.32M$ -18.24M$ -22.08M$ -20.00M
Operating Cash Flow$ -8.94M$ -12.50M$ -18.30M$ -21.82M$ -20.00M
Investing Cash Flow$ 9.45M$ 3.92M$ -48.74M$ 20.38M$ 31.89M
Financing Cash Flow---$ 60.00K$ 38.92M
Currency in USD

Ikena Oncology Earnings and Revenue History

Ikena Oncology Debt to Assets

Ikena Oncology Cash Flow

Ikena Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis